Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 10:31 am Purchase |
2020-12-31 | 13G | Vincerx Pharma, Inc. VINC |
RTW INVESTMENTS LP | 37,500 5.360% |
37,500 (New Position) |
Filing History |
| 2021-02-16 10:29 am Purchase |
2020-12-31 | 13G | LifeSci Acquisition II Corp. LSAQ |
RTW INVESTMENTS LP | 650,000 6.580% |
650,000 (New Position) |
Filing History |
| 2021-02-16 10:26 am Purchase |
2020-12-31 | 13G | FIVE PRIME THERAPEUTICS INC FPRX |
RTW INVESTMENTS LP | 2,515,788 5.730% |
2,515,788 (New Position) |
Filing History |
| 2021-02-12 10:15 am Purchase |
2020-12-31 | 13G | IVERIC bio, Inc. ISEE |
RTW INVESTMENTS LP | 6,722,624 7.510% |
600,742 (+9.81%) |
Filing History |
| 2021-02-12 10:12 am Unchanged |
2020-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
RTW INVESTMENTS LP | 2,071,409 7.540% |
0 (Unchanged) |
Filing History |
| 2021-02-12 10:08 am Sale |
2020-12-31 | 13G | Homology Medicines, Inc. FIXX |
RTW INVESTMENTS LP | 0 0.000% |
-241,625 (Position Closed) |
Filing History |
| 2021-02-12 10:06 am Purchase |
2020-12-31 | 13G | Establishment Labs Holdings Inc. ESTA |
RTW INVESTMENTS LP | 2,319,138 9.890% |
286,692 (+14.11%) |
Filing History |
| 2021-02-12 10:01 am Purchase |
2020-12-31 | 13G | Dicerna Pharmaceuticals, Inc. DRNA |
RTW INVESTMENTS LP | 7,253,857 9.670% |
1,379,628 (+23.49%) |
Filing History |
| 2021-02-12 09:58 am Purchase |
2020-12-31 | 13G | Cogent Biosciences, Inc. COGT |
RTW INVESTMENTS LP | 1,998,750 3.170% |
740,000 (+58.79%) |
Filing History |
| 2021-02-12 09:55 am Purchase |
2020-12-31 | 13G | Clearside Biomedical, Inc. CLSD |
RTW INVESTMENTS LP | 3,958,130 8.190% |
208,023 (+5.55%) |
Filing History |
| 2021-02-12 09:52 am Purchase |
2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
RTW INVESTMENTS LP | 3,422,855 8.660% |
1,537,855 (+81.58%) |
Filing History |
| 2021-02-12 09:51 am Purchase |
2021-02-12 | 13G | Exagen Inc. XGN |
RTW INVESTMENTS LP | 1,250,131 9.890% |
348,046 (+38.58%) |
Filing History |
| 2021-02-12 09:49 am Sale |
2020-12-31 | 13G | Wave Life Sciences Ltd. WVE |
RTW INVESTMENTS LP | 0 0.000% |
-2,414,027 (Position Closed) |
Filing History |
| 2021-02-12 09:47 am Purchase |
2020-12-31 | 13G | Vericel Corporation VCEL |
RTW INVESTMENTS LP | 4,517,570 9.940% |
1,528,141 (+51.12%) |
Filing History |
| 2021-02-12 09:46 am Purchase |
2020-12-31 | 13G | TELA Bio, Inc. TELA |
RTW INVESTMENTS LP | 1,383,816 9.590% |
244,458 (+21.46%) |
Filing History |
| 2021-02-12 09:44 am Sale |
2020-12-31 | 13G | Telesis Bio, Inc. TBIO |
RTW INVESTMENTS LP | 165,468 4.010% |
-18,132 (-9.88%) |
Filing History |
| 2021-02-12 09:42 am Unchanged |
2020-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
RTW INVESTMENTS LP | 2,463,601 12.130% |
0 (Unchanged) |
Filing History |
| 2021-02-12 09:40 am Unchanged |
2020-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
RTW INVESTMENTS LP | 3,544,248 9.890% |
0 (Unchanged) |
Filing History |
| 2021-02-12 09:39 am Purchase |
2020-12-31 | 13G | BrainsWay Ltd. BWAY |
RTW INVESTMENTS LP | 2,206,948 9.920% |
290,096 (+15.13%) |
Filing History |
| 2021-02-12 09:38 am Purchase |
2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
RTW INVESTMENTS LP | 1,512,673 9.310% |
256,816 (+20.45%) |
Filing History |